SECsense Logo

Lucid Diagnostics Inc. 8-K Report: Key Updates & Financial Insights

$LUCD
Form 8-K
Filed on: 2024-12-20
Source
Lucid Diagnostics Inc. 8-K Report: Key Updates & Financial Insights

Here's an analysis of the provided section of the financial report:

Key Information Extracted:

  1. Company Information:
  • Name: Lucid Diagnostics Inc.
  • CIK Number: 0001799011
  • Business Address: 360 Madison Avenue, 25th Floor, New York, NY 10017
  • Phone Number: (917) 813-1828
  • Stock Ticker: LUCD
  • Exchange: NASDAQ
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: December 19, 2024
  1. Financial Reporting Context:
  • Report Date: December 19, 2024
  • Period Covered: The report is as of December 19, 2024.
  1. Financial Metrics:
  • Currency: USD (U.S. Dollars)
  • Share Information: Common Stock with a par value of $0.001 per share.
  1. Identifiers:
  • SEC Central Index Key (CIK): 0001799011
  • IRS Employer Identification Number (EIN): 82-5488042
  • SEC File Number: 001-40901

Insights:

  • The report is a Form 8-K, which typically indicates that Lucid Diagnostics Inc. is reporting significant events or changes that shareholders should be aware of.
  • Given the date of the report, this could be related to year-end disclosures or significant corporate actions.
  • The presence of a par value for shares suggests that the company has a nominal value assigned to its common stock, which is standard practice and may be relevant for accounting and legal purposes.
  • As the report is current as of December 19, 2024, it is essential for stakeholders to review the details closely for any potential impacts on stock performance or corporate strategy.
  • The filing provides essential identifiers that could be used for further research into the company's financial health and regulatory compliance.

This summarized information is crucial for investors, analysts, and stakeholders monitoring Lucid Diagnostics Inc.'s developments and performance in the market.